Global Cardio Oncology Registry
A legfontosabb adatok
- Hol
- Weston (Egyesült Államok)A helyszín megnézése
Helyszínek itt: Egyesült Államok
- Cleveland Clinic FloridaWeston, Egyesült ÁllamokContact: Diego Sadler, MD FACCRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- The Cleveland Clinic
- Azonosító
- NCT05598879
- A regiszteradat frissítve
- 2026. május 12.
- Eredeti leírás
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.A teljes eredeti leírásKevesebb
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
Bevonási feltételek: New cardio-oncology consultation for breast cancer patients, or; New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or; New cardio-oncology consultation for acute or chronic leukemia patients, or; New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or; New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation; All patients have to be 18 years old or older.
Kizáró feltételek: Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators; Minors less than 18 years old; Inability or unwillingness to consent to participate.